Ning Luo1, Han Zhang2, Yang Zhou3, ZiXuan Kong1, WeiHang Sun1, Nan Huang4, AoDan Zhang1. 1. Department of Radiology, The Second Affiliated Hospital of Dalian Medical University, Dalian City, China. 2. Department of Radiology, Suizhou Hospital, Hubei University of Medicine, Suizhou Central Hospital, Hubei, China. 3. Department of Ultrasound, The First Affiliated Hospital of Dalian Medical University, Dalian City, China. 4. Medical Imaging Center, Taihe Hospital, Shi Yan City, Hubei Provence, China.
Abstract
PURPOSE: We aimed to explore the imaging findings of computed tomography (CT) in diagnosing coronavirus disease 2019 (COVID-19) and its clinical value for further evaluation of suspected cases. METHODS: Files of 155 patients visiting the fever clinics at our hospital and affiliated hospitals from January 20th to February 9th, 2020 were searched. Among them, 140 cases (including 82 males and 58 females) were included as suspected COVID-19 cases based on clinical and epidemiological history; the CT image features of 70 cases with suggestive findings on CT, confirmed by positive nucleic acid test were analyzed and evaluated. The sensitivity and specificity of CT in diagnosing COVID-19 were evaluated in patients with epidemiological history. RESULTS: Of the 70 patients, 84.3% showed bilateral lung involvement on CT; 27 cases (38.6%) showed ground-glass opacity (GGO), which was mostly distributed in the subpleural area (55.7%), and this sign was mainly observed in early COVID-19 patients. In addition, 41 cases (58.6%) manifested GGO combined with focal consolidation opacity, 2 (2.8%) had flake-like consolidation opacity, with involvements of the periphery of lung field and the central zone (44.3%), and this sign was mostly observed in severe or critical patients. Concomitant signs such as pleural effusion and mediastinal lymph node enlargement were rare. Among patients with epidemiological history, the sensitivity of CT in diagnosing COVID-19 was 89.7% (70/78), and the specificity was 88.7% (55/62). CONCLUSION: CT shows high sensitivity and specificity in diagnosing COVID-19. CT is an important examination method in evaluation of suspected cases and assessment of disease severity.
PURPOSE: We aimed to explore the imaging findings of computed tomography (CT) in diagnosing coronavirus disease 2019 (COVID-19) and its clinical value for further evaluation of suspected cases. METHODS: Files of 155 patients visiting the fever clinics at our hospital and affiliated hospitals from January 20th to February 9th, 2020 were searched. Among them, 140 cases (including 82 males and 58 females) were included as suspected COVID-19 cases based on clinical and epidemiological history; the CT image features of 70 cases with suggestive findings on CT, confirmed by positive nucleic acid test were analyzed and evaluated. The sensitivity and specificity of CT in diagnosing COVID-19 were evaluated in patients with epidemiological history. RESULTS: Of the 70 patients, 84.3% showed bilateral lung involvement on CT; 27 cases (38.6%) showed ground-glass opacity (GGO), which was mostly distributed in the subpleural area (55.7%), and this sign was mainly observed in early COVID-19patients. In addition, 41 cases (58.6%) manifested GGO combined with focal consolidation opacity, 2 (2.8%) had flake-like consolidation opacity, with involvements of the periphery of lung field and the central zone (44.3%), and this sign was mostly observed in severe or critical patients. Concomitant signs such as pleural effusion and mediastinal lymph node enlargement were rare. Among patients with epidemiological history, the sensitivity of CT in diagnosing COVID-19 was 89.7% (70/78), and the specificity was 88.7% (55/62). CONCLUSION: CT shows high sensitivity and specificity in diagnosing COVID-19. CT is an important examination method in evaluation of suspected cases and assessment of disease severity.
Authors: Geoffrey D Rubin; Christopher J Ryerson; Linda B Haramati; Nicola Sverzellati; Jeffrey P Kanne; Suhail Raoof; Neil W Schluger; Annalisa Volpi; Jae-Joon Yim; Ian B K Martin; Deverick J Anderson; Christina Kong; Talissa Altes; Andrew Bush; Sujal R Desai; Onathan Goldin; Jin Mo Goo; Marc Humbert; Yoshikazu Inoue; Hans-Ulrich Kauczor; Fengming Luo; Peter J Mazzone; Mathias Prokop; Martine Remy-Jardin; Luca Richeldi; Cornelia M Schaefer-Prokop; Noriyuki Tomiyama; Athol U Wells; Ann N Leung Journal: Radiology Date: 2020-04-07 Impact factor: 11.105
Authors: Lan T Phan; Thuong V Nguyen; Quang C Luong; Thinh V Nguyen; Hieu T Nguyen; Hung Q Le; Thuc T Nguyen; Thang M Cao; Quang D Pham Journal: N Engl J Med Date: 2020-01-28 Impact factor: 91.245
Authors: Michelle L Holshue; Chas DeBolt; Scott Lindquist; Kathy H Lofy; John Wiesman; Hollianne Bruce; Christopher Spitters; Keith Ericson; Sara Wilkerson; Ahmet Tural; George Diaz; Amanda Cohn; LeAnne Fox; Anita Patel; Susan I Gerber; Lindsay Kim; Suxiang Tong; Xiaoyan Lu; Steve Lindstrom; Mark A Pallansch; William C Weldon; Holly M Biggs; Timothy M Uyeki; Satish K Pillai Journal: N Engl J Med Date: 2020-01-31 Impact factor: 91.245
Authors: Nayaar Islam; Sanam Ebrahimzadeh; Jean-Paul Salameh; Sakib Kazi; Nicholas Fabiano; Lee Treanor; Marissa Absi; Zachary Hallgrimson; Mariska Mg Leeflang; Lotty Hooft; Christian B van der Pol; Ross Prager; Samanjit S Hare; Carole Dennie; René Spijker; Jonathan J Deeks; Jacqueline Dinnes; Kevin Jenniskens; Daniël A Korevaar; Jérémie F Cohen; Ann Van den Bruel; Yemisi Takwoingi; Janneke van de Wijgert; Johanna Aag Damen; Junfeng Wang; Matthew Df McInnes Journal: Cochrane Database Syst Rev Date: 2021-03-16
Authors: M Luigetti; R Iorio; A R Bentivoglio; L Tricoli; V Riso; J Marotta; C Piano; G Primiano; L Zileri Del Verme; M R Lo Monaco; P Calabresi Journal: Eur J Neurol Date: 2020-08-24 Impact factor: 6.288